Celgene (CELG) - 127.19 Buy Point
Chart courtesy of StockCharts.com
Sign in to check Buying Range, Stop-Loss, and Profit Targets. Don't have an account? Sign up for FREE — it only takes 30 seconds.

Celgene (CELG) – 127.19 Buy Point

March 6, 2017
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide.

Business Partnership

Stock Following, Inc. is looking for an accredited investor interested in starting a proprietary investment company capable of surpassing the results of George Soros' fund "Quantum".

Leave a Reply